Last reviewed · How we verify
Calcichew D3 — Competitive Intelligence Brief
marketed
Mineral supplement / Vitamin supplement combination
Bone health / Nutritional supplementation
Small molecule
Live · refreshed every 30 min
Target snapshot
Calcichew D3 (Calcichew D3) — Takeda. Calcichew D3 provides supplemental calcium and vitamin D3 to maintain adequate serum calcium and phosphate levels and support bone health.
Comparator set (1 drugs)
| Drug | Generic | Sponsor | Phase | Class | Target | Approval / PDUFA |
|---|---|---|---|---|---|---|
| Calcichew D3 TARGET | Calcichew D3 | Takeda | marketed | Mineral supplement / Vitamin supplement combination | ||
| Calcium carbonate/vitamin D3 | Calcium carbonate/vitamin D3 | University of Alberta | marketed | Mineral supplement / Vitamin supplement combination |
Recent regulatory actions (last 90 days)
Upcoming PDUFA dates (next 180 days)
Patent timeline (forward window)
Sponsor landscape (Mineral supplement / Vitamin supplement combination class)
- Takeda · 1 drug in this class
- University of Alberta · 1 drug in this class
Subscribe to ongoing alerts
Push every new event for this competitive set into your RSS reader, IFTTT/Zapier workflow, or email digest:
- Calcichew D3 CI watch — RSS
- Calcichew D3 CI watch — Atom
- Calcichew D3 CI watch — JSON
- Calcichew D3 alone — RSS
- Whole Mineral supplement / Vitamin supplement combination class — RSS
Cite this brief
Drug Landscape (2026). Calcichew D3 — Competitive Intelligence Brief. https://druglandscape.com/ci/calcichew-d3. Accessed 2026-05-13.
Build your own brief
Pick any drug + add comparators:
https://druglandscape.com/ci/{slug}— auto-detected competitorshttps://druglandscape.com/ci/{slug}?vs=drug1,drug2,drug3— explicit comparators- Brand names auto-resolve:
/ci/keytruda→ 301 →/ci/pembrolizumab